Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
27 Cards in this Set
- Front
- Back
systemic inflammation
|
inflammatory response to blood borne microbial molecules, tissue derived enzymes, and other proteins, pro-inflammatory mediators
|
|
systemic inflammatory response syndrome
|
two or more of the following; tachypnea, tachycardia, fever/hypothermia,neutrophilia/neutropenia
|
|
sepsis
|
systemic inflammatory response triggered by an microbial molecules (infection, damaged gut barrier, etc)
|
|
endotoxemia
|
systemic inflammation triggered by gram negative bacterial endotoxin
|
|
septic shock
|
sepsis w/signs of shock
|
|
what triggers inflammatory response?
|
microbial molecules absorbed into blood (lipopolysacharide-endotoxin), inflammation in sepsis is triggered by specific host receptors for microbial molecules (toll like receptors-TLRs)
|
|
wht does LPS induce?
|
COX-2 protein expression and activity
|
|
what is the pathophysiology of sepsis?
|
poor perfusion (neutrophil and platelet aggregates, thrombi, **hymodynamic shock-altered dysregulated peripheral vasculartone and poor cardiac output**, increased vascular permeability) and tissue injury (ischemia, edema, leukocyte products-reactive oxygen intermediates & degradative enzymes)
|
|
what diseases are commonly accompanied by systemic inflammation?
|
septicemia, endotoxemia/absorption of other microbial products from a site of infection (colic, colitis, pleuropneumonia, metritis, peritonitis, cellulitis), immune mediated dz (non-septic SIRS), severe trauma (non-septic SIRS)
|
|
what are the clinical signs of sepsis?
|
tachycardia, tachypnea, hyper/hypothermia, leukocytosis/penia, others (hyperemic mucous membranes, depression, edema, shock-prolonged CRT, poor peripheral pulses, hypotension, weak-trembling, cool extremities)
|
|
what are the typical lab findings on CBC of sepsis?
|
hemoconcentration (high RBC count, PCV, TP), systemic inflammation (high FB, high WBC, low mature PMN, high bands, low PLT)
|
|
what are the typical lab findings on chemistry of sepsis?
|
organ dysfunction (high creatinine, high BUN, high GGT, high AST), poor perfusion (low pH, high anion gap, high lactate, low pO2v-increased extraction)
|
|
what are the typical lab findings on UA of sepsis?
|
concentrated (high SG), hematuria/proteinuria
|
|
what are the principles of shock therapy?
|
stop absorption/treat source (hasten GI mucosal healing, drain abscesses, treat infections), antagonize LPS effects, **increase perfusion-increase BP, improve blood distribution, reduce vascular leak syndrome**, control coagulation/platelet activation
|
|
how do we use crystalloid fluids for shock?
|
isotonic fluids (effective if animal is dehydrated but not effective for treating shock because redistribute quickly to interstitial space), hypertonic-5% saline (increase cardiac output, increases perfusion during endotoxic shock), pressors (dopamine, dobutamine, norepinephrine-neonates)
|
|
how do we use colloid fluids for shock?
|
plasma (6-8L/d) & hetastarch (5-10ml/kg/d or eod) commonly used, increase cardiac outpu & increase perfusion, reduce endothelial permeability (vascular leak syndrome), long lasting compared to hypertonic crystalloid fluids
|
|
what can be used to antagonize LPS?
|
polymixin B, J5 plasma
|
|
what does polymixin B do?
|
binds LPS w/high affinity, blocks LPS binding to LPS-binding protein, blocks effects of LPS in vivo, potentially nephrotoxic, 2000-6000 IU/kg IV BID
|
|
what does J5 plasma do?
|
polyclonal anti-LPS antibody, protective against septic shock in at least one human study, improved clinical appearance at 48h after plasma and reduced mortality in horses with evidence of endotoxic shock (13% mortality in the treated vs 47% control)
|
|
what NSAID should be used for shock?
|
flunixin meglumine
|
|
what are the drawbacks of using NSAIDs for shock?
|
nephrotoxicity, GI mucosal ulceration/inhibited repair of injure mucosa, COX-2 inhibitors-debatable (Eqoxx, Meloxicam) mucosal damage
|
|
what does pentoxifylline do?
|
inhibits neutrophil and macrophage activation by LPS and reduces RBC stiffness
|
|
when should antibiotics be used?
|
neutrophil count is 1000 cells/uL or less, if septicemia is suspected/documented, source of infection causing spesis is found/documented
|
|
when should nutrition be supplemented?
|
anorexic horse or horses with restricted fod intake benefit from parenteral nutrition
|
|
when should DMSO be used?
|
NEVER
|
|
what is a general treatment plan?
|
SIRS (2-4L J5 plasma, polymyxin IV, LRS, flunixin IV), hypotensive (LRS bolus and twice maintenance, if still hypotensive hetastarch, consider pressors in neonates), monitor (PE, BP, colic, feet, veins, PCV/TP, creatinine, LFTs, urine)
|
|
how do we prevent laminitis?
|
circulatory support-include colloids, antiinflammatory drugs-aspirin (reduce platelet clumping) and pentoxyifyllin (increased deformability of RBC/WBC), handwalk, icing?
|